Department of Surgery, Indiana University, Amelia Collings, 545 Barnhill Dr., Emerson 125, Indianapolis, IN, USA.
TCU School of Medicine and Methodist Richardson Medical Center, Richardson, TX, USA.
Surg Endosc. 2022 May;36(5):2723-2733. doi: 10.1007/s00464-022-09133-w. Epub 2022 Mar 2.
SARS-CoV-2 has changed global healthcare since the pandemic began in 2020. The safety of minimally invasive surgery (MIS) utilizing insufflation from the standpoint of safety to the operating room personnel is currently being explored. The aims of this guideline are to examine the existing evidence to provide guidance regarding MIS for the patient with, or suspecting of having, the SARS-CoV-2 as well as the healthcare team involved.
Systematic literature reviews were conducted for 2 key questions (KQ) regarding the safety of MIS in the setting of COVID-19 pandemic. Reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis criteria. Evidence-based recommendations were formulated using a narrative synthesis of the literature by subject experts. Recommendations for future research were also proposed.
In KQ1, a total of 1361 articles were reviewed, with 2 articles meeting inclusion. In KQ2, a total of 977 articles were reviewed, with 4 articles met inclusions criteria, of which 2 studies reported on the SARS-CoV2 virus specifically. Despite many publications in the field, very little well-controlled and unbiased data exist to inform the recommendations. Of that which is available, it shows that both laparoscopic and open operations in Covid-positive patients had similar rates of OR staff positivity rates; however, patients who underwent laparoscopic procedures had a lower perioperative mortality than open procedures. Also, SARS-CoV-2 particles have been detected in the surgical plume at laparoscopy.
With demonstrated equivalence of operating room staff exposure, and noninferiority of laparoscopic access with respect to mortality, either laparoscopic or open approaches to abdominal operations may be used in patients with SARS-CoV-2. Measures should be employed for all laparoscopic or open cases to prevent exposure of operating room staff to the surgical plume, as virus can be present in this plume.
自 2020 年大流行开始以来,SARS-CoV-2 改变了全球医疗保健。目前正在从手术室人员安全的角度探索利用充气进行微创外科手术(MIS)的安全性。本指南的目的是检查现有证据,为患有或疑似患有 SARS-CoV-2 的患者以及参与的医疗保健团队提供有关 MIS 的指导。
针对 COVID-19 大流行期间 MIS 安全性的 2 个关键问题(KQ)进行了系统文献回顾。报告遵循系统评价和荟萃分析的首选报告项目标准。通过主题专家对文献的叙述性综合,制定了循证建议,并提出了未来研究的建议。
在 KQ1 中,共审查了 1361 篇文章,其中 2 篇符合纳入标准。在 KQ2 中,共审查了 977 篇文章,其中有 4 篇符合纳入标准,其中 2 项研究专门报道了 SARS-CoV2 病毒。尽管该领域有许多出版物,但几乎没有经过良好控制和无偏见的数据可以为建议提供信息。在所提供的内容中,表明在 Covid-阳性患者中进行腹腔镜和开放性手术的手术室工作人员阳性率相似;然而,接受腹腔镜手术的患者的围手术期死亡率低于开放性手术。此外,在腹腔镜手术中已检测到外科烟雾中的 SARS-CoV-2 颗粒。
鉴于手术室工作人员暴露的等效性,以及腹腔镜方法在死亡率方面的非劣效性,在 SARS-CoV-2 患者中可以使用腹腔镜或开放性腹部手术方法。应采取措施防止手术室工作人员暴露于外科烟雾,因为病毒可能存在于这种烟雾中。